Aurobindo Pharma lands in US patent litigation

Written by fe Bureau | Hyderabad | Updated: Apr 29 2014, 16:00pm hrs
Multinational pharma majors Hospira and Kowa Company have dragged Aurobindo Pharma to the court on allegations of patent infringement.

Hospira has alleged that Aurobindo's Abbreviated New Drug Application to make generic dexmedetomidine hydrochloride injection would infringe its patented drug Precedex.

"Of the Livalo patents, through the commercial manufacture, use, sale, offer for sale or importation into the United States of Aurobindo's pitavastatin drug product or any drug product containing Pitavastatin," Kowa prayed the court in its petition.